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THE elevation of the oc1-glycoprotein level in cancer and inflammatory diseases
has long been of interest. Miller, Bly, Watson and Bale (1951), Sarcione (1963)
and Richmond (1963) showed that in the normal rat these proteins were produced
in the liver. It has now been shown that in the tumour-bearing rat and in rat
bearing inflammatory lesions there is a significant increase in the rate of incor-
poration of1-14C-glucosamine into serumact-glycoprotein compared withthenormal
(Bekesi, Macbeth and Bice (1966), Schumer, Molnar, Dowling and Winzler, 1967).
The major problem now remaining is the way in which the tumour orinflammatory
lesion influences the liver to produce this increased synthesis. Several workers
have suggested that some factor may be released from the site ofthe lesion and act
upon the liver and the present work was instigated in order to investigate this
hypothesis.
Perfusion of the isolated liver was chosen for this work because conventional
parabiotic techniques would necessitate two rats, one tumour-bearing and hepa-
tectomised and one normal. Not only would this be difficult to carry out experi-
mentally, but in the light ofthe report by Bekesi et al. (1966) indicating synthesis
of glycoprotein by the tumour, it would not be valid.
Several other workers have reported the existence of a substance in the blood
from rats bearing turpentine induced inflammatory lesions, producing an increased
synthesis of serum al-glycoprotein by the perfused liver (Sarcione, Bohne and
Krauss, 1965; Gordon, 1966a; Gordon and Darcy, 1967; Schumer et al., 1967)
but the tumour-bearing rat has not been investigated. A preliminary account of
the present work has already been reported (Burston and Apsey, 1966).
METHODS AND MATERLALS
Animals.-Wistar albino rats obtained from A. Tuck & Son Ltd., Rayleigh,
Essex, were maintained on diet 41B (Oxo Ltd.) and water ad libitum. Sixteen
hours before the start of a perfusion experiment food but not water was removed
from both blood and liver donors. The Walker 256 carcino-sarcoma was obtained
from the Chester Beatty Institute and transplanted as described previously
(Burston, Apsey and Maclagan, 1965).
Perfusion medium
Blood was obtained immediately before perfusion from 15-18 female rats
weighing between 250-300 g. The animals were anaesthetised with ether and
bled by cardiac puncture into syringes containing 100 units of heparin (Boots
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pooled blood was adjusted to 30-40 units/ml. blood with heparin (5000 units/ml.),
and the blood was filtered through nylon stocking to remove any small clots.
Blood from normal rats was then diluted with 1/10 its volume of Ringers solution
before being placed in the perfusion apparatus. Inthe case ofblood from tumour-
bearing rats, this already had a large plasma volume and further dilution was
unnecessary.
Perfusion apparatus
Liver perfusion was carried out in an apparatus similar to that described by
Miller, Bly, Watson and Bale (1951) with the addition of a magnetic stirrer in the
perfusion medium reservoir and humidifying dishes within the perfusion cabinet
(Cohen and Gordon, 1958). The blood was oxygenated by a 95 % 02/5 % CO2
mixture and the temperature maintained at 370 C.
Operative procedure
The method of isolating the liver and transferring it to the perfusion chamber
was based on techniques reported by several workers. Male Wistar rats weighing
between 200-300 g. were anaesthetised with ether and the peritoneal cavity
opened. The bile duct and pancreatico-duodenal vessel were tied off. Two loose
ties were placed about the portal vein and 500 units of heparin was injected via
the penis vein. The inferior vena cava was then tied offbetween the liver and the
renal branch. The portal vein was tied off and cannulated, the thorax quickly
opened and the right auricle pierced. Perfusion was then commenced with
Ringers solution containing 5 % blood (Fisher and Kerly, 1964), the perfusate
runningto waste. With this technique the flowthrough theliverwas only stopped
for 1-5-2 minutes. The vena cava was then cannulated via the right auricle and
perfusion with whole blood started, the perfusate being returned to the reservoir.
Whilst blood was flowing the liver was dissected out and placed in the apparatus.
Thirty minutes after transferring the liver to the apparatus, approximately
25 ,uCi of D-galactose-1-14C 2-4 mCi/mm. (The Radiochemical Centre, Amer-
sham, Bucks.) was added to the perfusion medium.
Sample collection
In one series of experiments the perfusion medium was sampled immediately
after the addition of 1-14C-galactose and then at hourly intervals for a period of 4
hours. In other experiments the perfusion medium was sampled immediately
before the addition ofradioactive marker andthen 3 hours later at the termination
of the experiment. In both cases 3 ml. aliquots of the perfusion medium were
placed in tubes containing a few crystals of potassium oxalate. After mixing,
a sample (0.1 ml.) was withdrawn for estimation of blood glucose and a further
sample was taken for haematocrit determination. The remaining blood was
centrifuged at 3000 g for 10 minutes and the plasma stored at -15° C.
At the termination of perfusion the liver was perfused with 20 ml. Ringers
solution via the portal vein cannula. The liver washings were collected, centri-
fuged and the volume of the supernatant was measured. The liver was then
weighedand about 1 g. weighedinto 30%KOH forthe estimation ofliverglycogen.
The blood remaining in the perfusion apparatus was collected and the volume
measured. One ml. of the perfusion medium was removed for the estimation of
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activity in the red cells (see later) and the remaining blood was centrifuged at
3000 g for 30 minutes and the plasma removed. The perfusion apparatus was
then rinsed out with 50 ml. Ringers solution, the washings centrifuged and the
volume of supernatant measured. All specimens were stored at -15' C. until
required for analysis.
Finally the volume of KOH in the carbon dioxide trap was measured and a
small sample retained for the estimation ofradioactive CO2.
Analysis of samples
Haematocrit-this was measured in Wintrobe tubes by the method of Dacie
and Lewis (1963).
Total plasma protein was estimated by the biuret method ofGornall, Bardawill
and David (1949) and plasma haemoglobin by the oxyhaemoglobin method (King
and Wootton, 1956).
Plasma urea was estimated by the diacetylmonoxime method (Varley, 1963).
Blood glucose was determined by the glucose oxidase method (Marks, 1959) on
0-1 ml. of whole blood.
Liver glycogen was prepared as described by Hawk, Oser and Summerson
(1954) and hydrolysed for 4 hours with 1 N sulphuric acid. Glucose in the hydro-
lysate was then estimated by the glucose oxidase method above after neutralising
the sulphuric acid with barium carbonate. Radioactivity in the glycogen was
measured by adding 0-1 ml. of the hydrolysate to S ml. of scintillation fluid and
counting for 100 seconds.
Estimation of radioactivity
All samples containing 14C were counted by liquid scintillation counting in an
Ekco 610A scaler set at 15 volts discriminator bias and 1175 volts E.H.T., using
pharmaceutical phials containing 5 ml. of scintillation fluid. This was a mixture
ofp-dioxan, naphthalene, PPO and POPOP (Thorn Electronics Ltd.). Efficiency
was determined using 14C-Hexadecane, (0.781 #tCi/g., Radiochemical Centre,
Amersham, Bucks.) as an internal standard and was of the order of 50 %.
Samples were counted in eitheroftwo ways: aqueous non-protein samples were
added directly to the scintillation fluid (0.1 ml. sample to 5 ml. phosphor) allowed
to darkadaptfor 10minutes and countedintriplicate. Protein containingsamples
were treated as described below, dried at 1050 C. on to a coiled strip offilter paper
(5 x 1 cm.) in the counting bottles as described by Roodyn, Freeman and Tata
(1965); 5 ml. of phosphor was then added and after dark adapting the phials for
10 minutes counting was done in triplicate. The efficiency of this method was
checked against samples of 1-14C-galactose counted directly and on coils of filter
paper and was ofthe order of 30 %. With few exceptions the standard deviation
of the net count rate was not greater than ± 5 %. All counts were corrected to
100 % efficiency and a 25 4aCi dose.
Estimation of total incorporation of 1-14C-galactose
Plasma and liver washings.-These were diluted 1 : 20 and 1: 10 respectively
with 1-7 N ammonium hydroxide and 0x1 ml. counted on strips of filter paper.
Apparatus washings.- 01 ml. was placed directly on to a filter paper strip
and dried before counting.
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Liver.-About 1 g. of liver was weighed into 5 ml. 30% KOH and boiled for
20 minutes. After cooling the volume was measured and 0.1 ml. was added to
5 ml. 0*1 N hydrochloric acid, and 0.1 ml. ofthis solution counted on a filter paper
strip.
Red blood cells.-The red cells from 1 ml. ofblood were washed twice with 3 ml.
ofRingers solution and lysed with 3 ml. of 1 7 N ammonium hydroxide. A volume
(0.1 ml.) ofthe lysate was counted on a filter paper strip.
Carbon dioxide.-Carbon dioxide was precipitated from the KOH solution as
barium carbonate. The precipitate was filtered off, washed with water, and the
filter paper plus precipitate was dried at 1050 C. before being placed in a solution
of phosphor for scintillation counting.
Calculation.-The blood volume in circulation at the end of the perfusion was
estimated by the method of Gordon (1957).
Preparation ofplarsma HC104 soluble and insoluble fractions
A volume (0-2 ml.) ofplasma was added to 1-8 ml. ofa solution of 1 % galactose
in water and 1 ml. of 1-8 N HC104 was added. After standing for 10 minutes the
precipitate was sedimented at 7000 g, the supernatant removed and the precipitate
dissolved in 1 0 ml. of 1 M NaOH and treated as described below. To an aliquot
(2.5 ml.) of the supernatant 0-5 ml. of phosphotungstic acid (5 % in 2 N HCI) was
added and after standing for 10 minutes the mixture was centrifuged at 3000 g.
The phosphotungstic acid precipitate was washed three times by stirring with
2 ml. portions of a 0-1 % solution of galactose in a 95 % ethanol/5 % water (v/v)
mixture, centrifuging at 3000 g after each wash. The precipitate was then dis-
solved in 0-3 ml. of 1-7 N NH40H and protein was estimated by the method of
Lowry, Rosebrough, Farr and Randall (1951) on a sample of 0-1 ml. A second
0*1 ml. sample was dried on to a filter paper strip for estimation ofradioactivity.
The alkaline solution of the perchloric acid insoluble fraction (above) was
precipitated with 0 5 ml. phosphotungstic acid in HC1. After centrifuging for
10 minutes at 7000 g the precipitate was washed twice by suspending in 4 ml.
ethanol-galactose solution as above. The washed precipitate was redissolved in
1 ml. M NaOH and reprecipitated with 05 ml. phosphotungstic acid in order to
aid solution in 0 5 ml. 1*7 N NH40H. The total volume of the solution was
measured and 0-1 ml. was dried on to a filter paper strip for the estimation of
radioactivity. A further 0 3 ml. was diluted to 1 ml. with water and protein
estimated by the biuret method.
RESULTS
In preliminary experiments (Burston and Apsey, 1966) the incorporation of
1-14C-galactose into the serum glycoprotein fraction was studied as a function of
time. A typical example is shown in Fig. 1. It can be seen from this that there
is an initial rapid incorporation oflabel followed by a slowerincorporationreaching
a maximum between 3 and 4 hours. In the present study, as only a single specific
activity measurement was required the livers were perfused for 3 hours after the
addition of 1-14C-galactose to the system.
The various parameters measured on each sample are shown in Table I.
The results for normal liver perfused with normal blood agree generally with
those published by other workers (Cohen and Gordon, 1958; Fisher and Kerly,
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1964). When the three perfusion systems are compared, however, some variations
are seen. The two systems using normal blood are similar as might be expected,
except for blood glucose. The liver from tumour-bearing rats is poor in main-
taining an increased blood glucose level during the course ofperfusion. This was
also found in our previous study (Burston and Apsey, 1966). In the system using
blood from tumour-bearing animals there are some differences from normal blood
as might be expected. The initial haematocrit is decreased, while there is a
threefold increase in the plasma glycoprotein level. There is a significant increase
in the terminal liver glycogen level, although the blood glucose level is normal.
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FIG. 1.-Incorporation of 1-14C-galactose into HC104 soluble and insoluble fraction ofrat plasma
by a normal rat liver perfused with normal rat blocd.
In order to study the incorporation of 1-14C-galactose into the glycoprotein
fraction, plasma protein was divided into two fractions, those proteins soluble in
06 N HC104 andthose insoluble. Although the former fraction is immunologically
heterogeneous, quantitatively it is composed mainly ofoc,-globulin of the human
orosomucoid type. Changes in the level of this protein correlate with the rapid
growth phase of the Walker tumour (Burston, Apsey and Maclagan, 1965).
Therefore this fraction should reflect any difference in the rate ofincorporation of
1-14C-galactose by the liver when perfused with blood from tumour-bearing rats
or liver from tumour-bearing rats perfused with nornmal blood.
It can be seen from Fig. 2 that there is a significant increase inthe incorporation
of 1-14C-galactose into the HC104 soluble fraction of rat plasma by livers from
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tumour-bearing rats perfused with normal blood whether expressed as specific
activity (A) (p < 0.02) or in terms of total incorporation/100 g. liver (B) or as a
percentage of the dose (C) (p < 0.05). In the case of normal liver perfused with
blood from tumour-bearing rats there is a significant decrease in specific activity.
This is presumably due to the threefold increase in the level of HC104 soluble
protein in the perfusing blood since when the results are expressed either in terms
of total incorporation/100 g. liver or as a percentage of the dose/100 g. liver, the
latter group becomes similar to the normal liver/normal blood group.
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tumour-bearing rats.
* Normal liver perfused with normal blood.
o Normal liver perfused with blood from tumour-bearing rats.
AL Liver from tumour-bearing rats perfused with normal blood.
(A) Specific activity, disintegrations per minute per mg. HCl04 soluble protein.
(B) Total incorporation into HC0l4 soluble protein per 100 g. liver.
(C) Total incorporation into HCIO,4 soluble protein per 100 g. liver as percentage of dose.
The specific activity and total incorporation of 1_14C-galactose into the HC104
insoluble fraction are shown in Fig. 3. It can be seen that in the case of livers
fromtumour-bearingratsperfused with normal bloodalthough the specific activity
(A) is similar to the normal there is a suggestion of an increase in the total incor-
poration of 1_14C-galactose (B) but this is not statistically significant. When
normal livers were perfused with blood from tumour-bearing rats, on the other
hand, both the specific activity of and the total incorporation into the HC1O4
insoluble fraction were similar to the control group.
DISCUSSION
The work reported here was undertaken in order to determine ifthe rise in the
level ofH0104 soluble protein in rat plasma in cancer was produced by means of a
humoral mechanism stimulating the liver. Gordon (1966b) has discussed the808 D. BURSTON AND M. E. APSEY
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FiG. 3.-Incorporation of 1-14C-galactose into HC104 insoluble fraction of rat plasma by livers
from normal and tumour-bearing rats, perfused for 3 hours with blood from normal and
tumour-bearing rats.
* Normal liver perfused with normal blood.
O Normal liver perfused with blood from tumour-bearing rats.
A Liver from tumour-bearing rats perfused with normal blood.
(A) Specific activity, disintegrations per minute per mg. HC104 insoluble protein.
(B) Total incorporation into HCl04 insoluble protein per 100 g. liver.
(C) Total incorporation into HC104 insoluble protein per 100 g. liver as percentage of dose.
assumptions that must be made for the relative rates of synthesis of plasma
proteins by the liver to be proportional to the observed specific activities ofthese
proteins. Ofthese, measurement at maximum specific activity, the assumption of
an insignificant amount of catabolism of the newly formed protein and correction
for differing amounts of protein present in the perfusing plasma are the most
important.
In the present work specific activitv measurements were made 3 hours after
the addition of 1-14C-galactose to the perfusing medium, this being the time of
maximum incorporation when normal liver was perfused with normal blood.
When normal liver and liver from tumour-bearing rats were perfused with normal
blood, the level ofperchloric acid soluble protein in the perfusing blood was similar
so that no correction is needed for differences in protein level and the two systems
are directly comparable. In the case of normal liver perfused with blood from
tumour-bearing rats there is a threefold increase in the plasma glycoprotein level
in the perfusing blood. This will produce a dilution of labelled protein in the
plasma and therefore in order to compare directly this system with the normal,
specific activities must be corrected or the results must be expressed in terms of
total incorporation which does not involve knowledge of the initial protein levels.
It is obvious from the results that, whether expressed in terms of specific
activity or total incorporation, there is no significant increase in the incorporation
of 1-4C-galactose into perchloric acid soluble protein by normal liver when
perfused with blood from tumour-bearing rats. This would suggest at first sightGLYCOPROTEIN SYNTHESIS BY RAT LIVER
that there'is no hormone present in plasma from the tumour-bearing rat causing
an increased rate of synthesis by the perfused normal liver. This is in contrast
to the results of Gordon and Darcy (1967) who showed that normal liver perfused
with blood from turpentine injected animals synthesised the ox,-globulin of Darcy
at a greatly increased rate. This system used by Gordon, however, differed from
the one described here in that the labelled precursor was supplied continuously
throughout the perfusion, so maintaining an almost constant precursor specific
activity and a linear increase in protein specific activity. When the dose is given
as a single addition to the perfusate there is a rapid rise in precursor in the liver
followed by a falling off, giving rise to a plateau in the specific activity-time curve.
Therefore, unless any hormone present in the blood acts within 30 minutes to
1 hour from the time of connecting the liver to the system-then it is unlikely
that the effect would be apparent as an increase in incorporation of a dose given
30 minutes after the start of the perfusion.
The results reported here are at variance with those reported by Schumer et al.
(1967) who found an increase in the total incorporation of 1-14C-glucosamine into
perchloric acid soluble protein by normal rat liver perfused with blood from
turpentine injected rats. These workers used a single dose ofisotope added to the
medium at the start of the perfusion. The effect appeared to be specific for the
perchloric acid soluble fraction as the total incorporation into the HC104 insoluble
fraction decreased.
In the case of liver from tumour-bearing rats perfused with normal blood the
results show that here there is a significant increase in incorporation oflabel into
the HC104 soluble protein compared with the normal. This indicates that the
tumour brings about some more permanent change in the liver. Gordon and
Darcy (1967) have indicated two possibilities, either an increase in the number of
cells synthesising a given protein at a given time, or an increase in the rate of
synthesis by a cell previously synthesising protein at the normal rate. The
present experiments do not differentiate between either ofthese hypotheses. The
increased incorporation into the HC104 insoluble fraction by liver from tumour-
bearing rats, although not statistically significant, may be due to increased rates
of synthesis of several ac2-globulins the levels of which are elevated in cancer and
the synthesis of which may be stimulated at the same time as the synthesis of
ocl-globulin.
In conclusion therefore it appears from the present study that if tumours do
produce a substance causing an increase in the rate ofsynthesis ofperchloric acid
soluble protein by the liver the effect is not a rapid one but must take time to
become effective. Once altered, however, the liverretains the ability to synthesise
these proteins at an increased rate when isolated and perfused. The nature ofthe
change in the liver whether cellular or subcellular awaits further investigation.
SUMMARY
The isolated perfused livers from normal and tumour-bearing rats have been
used to measure the incorporation of 1-14C-galactose into the HC104 soluble and
insoluble proteins of plasma from normal and tumour-bearing rats.
It was found that after 3 hours' perfusion of livers from tumour-bearing rats
with normal rat blood there was a significant increase in specific activity and total
incorporation of 1-14C-galactose into HC104 soluble plasma protein, and a smaller
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increase in the HC104 insoluble protein compared with normal liver perfused with
normal blood.
When normal rat livers were perfused with blood from tumour-bearing rats
no increase inspecific activityortotalincorporation of1-14C-galactose wasobserved
in either HC104 soluble or insoluble fractions.
The significance of these results is discussed.
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